In this issue:
Infection/cancer risk with biologics in elderly IBD patients
Vedolizumab vs. infliximab in UC after initial anti-TNF failure
Pregnancy outcomes in IBD
Tacrolimus induces short- not long-term clinical response in IBD
Faecal/colon microbiome features and response to biologics in IBD
Placebo responses by endoscopic evaluation of CD activity
Acute VTE risk after discharge from hospital in IBD
Gene expression for predicting endoscopic remission after vedolizumab for IBD
Please login below to download this issue (PDF)